Health Sciences Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Health Sciences stocks.

Health Sciences Stocks Recent News

Date Stock Title
Jul 1 SNY Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
Jul 1 SNY Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons
Jul 1 SNY Jim Cramer Says You Should Not Buy Novavax Inc (NASDAQ:NVAX)
Jul 1 SNY Sanofi reports findings from Phase II relapsing MS treatment trial
Jul 1 SNY Sanofi eyes German insulin investment of up to $1.6 billion, source says
Jun 29 SNY Where Will Novavax Be in 1 Year?
Jun 28 SNY PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
Jun 28 SNY 3 Top Euronext Paris Dividend Stocks With Yields From 4% To 5.1%
Jun 27 SNY Vigil Neuroscience jumps 34% as Sanofi invests $40M
Jun 27 SNY Formation Bio secures $372m funds for AI-driven drug platform
Jun 27 SNY Sanofi reports positive data from Phase III EoE treatment trial
Jun 26 SNY Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine
Jun 26 SNY Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM
Jun 26 SNY Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
Jun 26 GDRX GoodRx Launches New "Prescription Cost Tracker" to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.
Jun 26 SNY Sanofi reports data from Phase II demyelinating polyneuropathy trial
Jun 26 SNY Pharma M&A: The top high value deals in 2023
Jun 25 SNY Sanofi reportedly seeking early bids for $20B consumer care spinoff
Jun 25 SNY Press Release: Availability of the Q2 2024 Aide-mémoire
Jun 25 SNY Sanofi Seeks Initial Offers for Its $20 Billion Consumer Arm
Health Sciences

The following outline is provided as an overview of and topical guide to health sciences:
Health sciences – are those sciences which focus on health, or health care, as core parts of their subject matter. Because these two subject matter relate to multiple academic disciplines, both STEM disciplines as well as emerging patient safety disciplines (such as social care research) are relevant to current health scientific knowledge.
Health sciences knowledge bases are currently diverse, with intellectual foundations which are sometimes mutually-inconsistent. There is currently an existing bias in the field, towards high valuation of knowledge deriving from controlling views on human agency (as epitomized by the epistemological basis of Randomized Control Trial designs); compare this against the more naturalistic views on human agency taken by research based on Ethnography for example).

Browse All Tags